Philips Buys Respironics For $5.1 Bil. To Build Home Health Care Business

Philips will add obstructive sleep apnea and respiratory care products to its burgeoning home health care franchise through the $5.1 billion acquisition of Respironics, announced Dec. 21

More from Archive

More from Medtech Insight